HCA Healthcare, Inc.·4

May 13, 5:08 PM ET

Cuffe Michael S. 4

4 · HCA Healthcare, Inc. · Filed May 13, 2024

Insider Transaction Report

Form 4
Period: 2024-05-09
Cuffe Michael S.
EVP and Chief Clinical Officer
Transactions
  • Sale

    Common Stock

    2024-05-09$316.88/sh6,311$1,999,82529,623.969 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.7603 to $317.07, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT